Vascular devices can be referred to as a medical device, utilized in the case of catheterization post a cardiovascular surgery, for the closure and achieving haemostasis in the artery. Rising demand for minimally-invasive procedures, especially for peripheral arterial disease, lifestyle changes, increase in aging population, and technological advancements are some of the factors that have supported long-term expansion for Peripheral Vascular Devices Market.
The data in the report is derived from dynamic market forecast models. This uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The global interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1% from 2016 to 2021.
The global interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1% from 2016 to 2021.
Global Peripheral Vascular & Interventional Cardiology Devices Market was valued at $8.7 billion in 2011 and is poised to grow at a CAGR of 7.8% to reach $12.7 billion by 2016.
[475 Pages Report] Interventional Cardiology Devices Market was valued at $8.7 billion in 2011 and is poised to grow at a CAGR of 7.8% to reach $12.7 billion by 2016 - A PPT
The global market for Vascular Grafts is expected to witness a rise in its initial estimated value of USD 2.54 billion in 2018 to USD 4.05 billion by 2026, registering a CAGR of 6% in the forecast period of 2019-2026, this rise in value is related to the rising preference of minimally invasive surgeries.
An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.
According to the latest research report by IMARC Group, The global vascular stents market size reached US$ 10.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. More Info:- https://www.imarcgroup.com/vascular-stents-market
According to the latest research report by IMARC Group, The global vascular grafts market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. More Info:- https://www.imarcgroup.com/vascular-grafts-market
The global occlusion devices market is projected to be worth USD 4,378.5 Million by 2027, according to a current analysis by Emergen Research. The occlusion devices market is observing high demand attributed to the rising incidence of neurological devices. Several million individuals throughout the world are suffering from neurological disorders, and over 6 million individuals die yearly on account of stroke, with over 80.0% of the deaths occurring in low and middle-income regions. A common application of neurological embolization devices (occlusion devices) is the aneurysm coil embolization procedure, which is deployed in the treatment of brain aneurysms. Brain aneurysms embolization deploys imaging guidance to put small metallic coils into the aneurysm to prevent the blood flow and stop the bursting of the aneurysm.
According to the latest research report by IMARC Group, The global vascular grafts market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028. More Info:- https://www.imarcgroup.com/vascular-grafts-market
Unarguably, the COVID-19 pandemic has severely impacted the market in the year 2020. There has been a huge decline in procedural volumes at catheterization laboratories and ambulatory surgical centers. Patients during the pandemic were not able to visit clinics located at highly affected areas. In view of this, peripheral interventions businesses witnessed moderate impact in the starting phase of the pandemic
Get more details @ http://bit.ly/2qPzjDm Bioabsorbable Vascular Stents Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Russia, China, India, Japan, Malaysia, Thailand, Indonesia, Australia, Brazil, Saudi Arabia, UAE, South Africa), Application Growth Potential, Competitive Market Growth & Forecast, 2017 – 2024
The Global Vascular Access Device market is valued of $4174.4mn at a CAGR of 6.1% during the forecast period 2017 -2023. Government initiatives along with the growing awareness about kidney failures, diabetes and cancer are expected to be the main drivers of this vascular access device market. North-America vascular access device market accounted for over 42% of the total industry share in 2017.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
The global thrombectomy devices market is expected to reach a value of USD 1.45 Billion by 2022; growing at a CAGR of 6.7% during the forecast period. A number of factors such as growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are driving the growth of the market. However, the stringent regulatory scenario, limited patient awareness resulting in delayed treatment for peripheral vascular diseases, and dearth of skilled & well-trained surgeons to perform thrombectomy procedures are the key challenges faced by majority of the thrombectomy devices manufacturers across the globe in the global market.
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of neurological disorders. Development of subcutaneous implantable cardioverter defibrillators along with the increasing demand from developing nations is expected to create ample growth opportunities in the global active implantable medical devices market.
The global thrombectomy devices market is expected to reach a value of USD 1.45 Billion by 2022; growing at a CAGR of 6.7% during the forecast period. A number of factors such as growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are driving the growth of the market. However, the stringent regulatory scenario, limited patient awareness resulting in delayed treatment for peripheral vascular diseases, and dearth of skilled & well-trained surgeons to perform thrombectomy procedures are the key challenges faced by majority of the thrombectomy devices manufacturers across the globe in the global market.
The global vascular interventional devices market consist of devices used in both coronary and peripheral endovascular procedures which includes balloons, EVAR stent grafts, IVC filters, IVUS & angiography catheters, plaque modification devices, hemodynamic flow alteration devices and accessory devices. The interventional cardiology devices market was valued at $8.7 billion in 2011 and is poised to grow at a CAGR of 7.8% to reach $12.7 billion by 2016.
Global drug eluting balloons catheters market size is expected to reach $2.35 Bn by 2028 at a rate of 13.2%, segmented as by product, coronary artery disease drug-eluting balloon catheters, peripheral vascular disease drug-eluting balloon catheters
Axiom Market Research & Consulting™ added a,” Vascular Access Device Market report 2018-2024, based on a deep market analysis with inputs from industry experts. Vascular Access Device Market by Type (Peripheral, Central, Accessories), Application (Diagnostic Testing, and Medication Administration) & End Users (Hospitals, Ambulatory Surgery Centres) - Global Forecasts to 2024. Top key players of this market Dickinson and Company, Cook Medical, Medtronic plc.
The vascular guidewires market is expected to exhibit significant growth during the forecast period due to rise in the prevalence of cardiovascular disorders, increase in geriatric population, demand for minimally invasive procedures, and rapid technological advancements in guidewires drive the market growth.
The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028.
Big Market Research has announced a new Report Package "Intraoperative Neuromonitoring Market in the US -Size, Share, Trends, Forecast,Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/intraoperative-neuromonitoring-in-the-us-2015-2019-market Intraoperative neuromonitoring (IONM) technology involves the use of IONM devices to assess the function of the nerves and spinal cord during surgeries. It can be used in various surgical procedures including neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, cardiac surgery, genitourinary surgery, interventional radiological procedures, and other general surgeries. Enquire About This Report at: http://www.bigmarketresearch.com/report-enquiry/169898
Artificial blood vessels are synthetic constructs designed to replace damaged or diseased blood vessels, offering a life-saving solution for patients. Read More
The increase in the number of patients in hospitals and rise in the prevalence of diseases are driving the market for peripheral intravenous catheters.
A vascular stent is a mesh-like tube of thin wires developed using stainless steel or alloys. The device helps prevent arterial blockages that may occur in people who have undergone angioplasty. It helps maintain the patency of stenotic vessels and avoid re-blockage due to blood accumulation or excessive tissue growth.The analysts forecast global vascular stents market to grow at a CAGR of 7.38% during the period 2016-2020. Complete Report available at http://www.sandlerresearch.org/global-vascular-stents-market-2016-2020.html.
The global neurovascular devices/interventional neurology market is set to witness growth at a CAGR of 5.23%, during the forecast period, 2023-2032. Read More
Aesthetic Laser Market report gives key business sector information on the brazil aesthetic lasers and energy devices market. The goal is to give data that speaks to the most state-of-the-art information of the aesthetic laser market size. Browse full report @ http://bit.ly/1KYw1l6
The global endoscopy guidewire market is projected to register growth at a CAGR of 5.40% during forecast the period 2023-2032. Get more insights into the blog
This report identifies the global guidewires market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers,
The global neurovascular devices/interventional neurology market is growing at a CAGR of 5.23% during the forecast period 2023-2032. Request Free Sample Report.
Leg pain caused and reproduced by a certain degree of exertion ... in Japan for the treatment of leg ischemia and ulcers ... NEED FOR LEG BYPASS SURGERY ...
According to the latest research report by IMARC Group, The global atherectomy devices market size reached US$ 978.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,476.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032. More Info:- https://www.imarcgroup.com/atherectomy-devices-market